GI
ADPT icon

GAMMA Investing’s Adaptive Biotechnologies ADPT Stock Holding History

GAMMA Investing’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$386K Buy
13,366
+253
+2% +$6.21K 0.01% 850
2026
Q2 		$281K Sell
13,113
-68
-0.5% -$1.04K 0.01% 1021
2026
Q1 		$183K Buy
13,181
+60
+0.5% +$956 0.01% 1187
2025
Q4 		$213K Buy
13,121
+181
+1% +$2.95K 0.01% 992
2025
Q3 		$194K Buy
12,940
+16
+0.1% +$195 0.01% 1005
2025
Q2 		$151K Sell
12,924
-469
-4% -$4.26K 0.01% 1111
2025
Q1 		$99.5K Buy
13,393
+3,583
+37% +$27.5K 0.01% 1260
2024
Q4 		$58.8K Buy
+9,810
New +$54.1K 0.01% 1534
2024
Q3 		– Sell
-216
Closed -$782 – 3578
2024
Q2 		$782 Sell
216
-191
-47% -$606 ﹤0.01% 3115
2024
Q1 		$1.31K Hold
407
– – ﹤0.01% 2878
2023
Q4 		$1.49K Buy
+407
New +$1.86K ﹤0.01% 2674

Other funds holding ADPT

WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's ADPT Position: Q3 2026 in Review

GAMMA Investing increased its Adaptive Biotechnologies (ADPT) stake by 1.9% in Q3 2026, buying an estimated $6.21K and bringing the position to 13,366 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #850.

GAMMA Investing first reported a position in ADPT in Q4 2023 and has held it in 11 quarters since. 8 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • GAMMA Investing held 13,366 shares of Adaptive Biotechnologies worth $386K as of Q3 2026.
  • GAMMA Investing bought 253 Adaptive Biotechnologies shares in Q3 2026, an estimated $6.21K.
  • Adaptive Biotechnologies made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #850 holding.
  • GAMMA Investing first reported a position in Adaptive Biotechnologies in Q4 2023 and has held it in 11 quarters since.
  • 8 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.